Document is current
Any future updates will be listed below
-
Authors
Xu, Qiongqian
He, Xixi
Mou, Yaru
Sun, Dong
Zhang, Xintao
Han, Jichang
Liu, Xiaoyang
Liu, Xingjian
Ren, Xue
Wang, Dongming
Wang, Jian
Ma, Chuncan
Zhang, Qiangye
Li, Aiwu
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (No. 82271743, No.82071682)
The Development Fund of Qilu Hospital of Shandong University (34641390220001)
Natural Science Foundation of Shandong Province (No. ZR2022MH276, No.ZR2021MH210)
the Natural Science Foundation of Shandong Province (No.ZR2021MH334)
Natural Science Foundation regional joint fund project of Hunan Province (2024JJ7555)
- License Information
-
More Information
Article History
Received: 2 September 2024
Accepted: 18 December 2024
First Online: 23 January 2025
Declarations
:
: The protocols for animal studies was ethically approved by the Ethics Committee of Qilu Hospital, Shandong University (Approval Nos. DMLL-2023–008). The ethical approval was granted for the study titled "Mechanism of TIMP3 Activation of the Shh/Gli Pathway in Regulating Neuroligins Genes to Induce Hirschsprung's Disease," dated January 1, 2023. This study does not involve any experiments related to human cells or tissues.
: Not applicable.
: The authors declare no competing interests.
